The summarized graph for the values of the coefficients of significant linear trends. by Ekaterina Ivanova (230383)

Pixel-wise trends in annual time series data of NDVI and Tmin during 1982 to 2015 (a) Sen’s slope of NDVI (b) p-values of NDVI, (c)significant trends (p<0.05) in average annual slo... by Jamal Hassan Ougahi (13513875)

Subjects:

Increasing gaps and decreasing returns attenuate spending effects. by William Minozzi (8564712)

Binary comparison matrix of increasing and decreasing trends in fire density from summer to autumn and comparison of different cases of spatial overlap of these spatial trends. by Peyman Karami (5909264)

Results of the M-K test in different seasons (significant level is 0.05). by Wang Runke (13256851)

Subjects:

Table 6 - Gain and loss: Human and environmental wellbeing – drivers of Kilimanjaro’s decreasing biodiversity by Andreas Hemp (730415)

The figure shows that <i>R</i>₀ decreases significantly under control strategies, particularly at temperatures near the peak transmission range, indicating the effectiveness of control mechanisms applied. by Lukas Degu Petros (22097332)

“…<p>The figure shows that <i>R</i>₀ decreases significantly under control strategies, particularly at temperatures near the peak transmission range, indicating the effectiveness of control mechanisms applied.…”

The trend of risk scores. by Ayako Shoji (78037)

Subjects:

Summary of significance levels for comparison of surgical segment ROM between different test groups. by Jia Zhu (135506)

Subjects:

P values of Kruskal–Wallis test at 95% significance level. by Fahd Saeed Alakbari (10701871)

Subjects:

Meta-regression analysis of the prevalence of neonatal sepsis in Iran according to implementation years of screening showing a statistically non-significant decreasing trend in prevalence in recent years (c = -0.005; <i>P</i> value = 0.4). by Zahra Akbarian-Rad (8356659)

“…<p>Meta-regression analysis of the prevalence of neonatal sepsis in Iran according to implementation years of screening showing a statistically non-significant decreasing trend in prevalence in recent years (c = -0.005; <i>P</i> value = 0.4).…”

Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

The trend of patient characteristics, risk factors, and risk scores. by Ayako Shoji (78037)

Subjects:

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Results of the parallel trend test. by Le Zhu (1771669)

Subjects:

Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

Subjects: